Recombinant Salmonella paratyphi C Bifunctional protein aas (aas) plays a crucial role in lysophospholipid acylation. It facilitates the transfer of fatty acids to the 1-position of lysophospholipids via an enzyme-bound acyl-ACP intermediate, requiring ATP and magnesium. This enzyme's physiological function is the regeneration of phosphatidylethanolamine from 2-acyl-glycero-3-phosphoethanolamine (2-acyl-GPE), which is produced through transacylation reactions or phospholipase A1 degradation.
KEGG: sei:SPC_3068
Bifunctional protein Aas (encoded by the aas gene) is a full-length protein found in various Salmonella serovars. In Salmonella paratyphi B, it consists of 719 amino acids with the sequence beginning with MLFGFFRNLFRVLYRVRVTGDVRALQGNRVLITPNHVSFIDGMLLALFLPVRPVFAVYTS and continuing through its full length . The "bifunctional" designation suggests dual enzymatic activities, likely related to bacterial metabolism and potential roles in pathogenesis. While specific Aas functions aren't directly addressed in the available research, its conservation across Salmonella strains suggests biological importance.
S. paratyphi C is a human-adapted typhoid agent that causes systemic infection. Genomic analysis of S. paratyphi C strain RKS4594 reveals it does not share a common ancestor with other human-adapted typhoid agents like S. typhi . Instead, S. paratyphi C has diverged from a common ancestor with S. choleraesuis (primarily a swine pathogen). RKS4594 shares 4,346 genes with S. choleraesuis but only 4,008 genes with S. typhi . This supports a convergent evolution model where different typhoid agents acquired similar pathogenic traits independently rather than inheriting them from a common ancestor.
| Feature | S. paratyphi C (RKS4594) | S. choleraesuis | S. typhi |
|---|---|---|---|
| Chromosome size | 4,833,080 bp | Not specified | Not specified |
| Plasmid size | 55,414 bp | Not specified | Not specified |
| Coding sequences | 4,640 (4,578 in chromosome, 62 in plasmid) | Not specified | Not specified |
| Pseudogenes | 152 (149 in chromosome, 3 in plasmid) | Not specified | Not specified |
| Shared genes with S. paratyphi C | - | 4,346 | 4,008 |
| Primary host | Human | Swine | Human |
Based on data from S. paratyphi B, recombinant Aas protein consists of 719 amino acids and is typically expressed with an N-terminal His tag to facilitate purification . The protein's complete amino acid sequence has been characterized, and when properly expressed, it demonstrates >90% purity as determined by SDS-PAGE . While specific data for S. paratyphi C Aas isn't provided in the search results, we can infer similar structural properties with sequence variations reflecting evolutionary divergence between strains.
E. coli expression systems have been successfully used to produce recombinant Aas protein . When designing expression constructs, researchers should:
Include the full-length coding sequence (1-719 amino acids for S. paratyphi B)
Add an N-terminal His tag for purification purposes
Select expression vectors with appropriate promoters for controlled expression
Optimize codon usage if necessary for efficient translation
Consider induction conditions that maximize protein solubility
While working with expression systems, researchers should be aware that bacterial proteins may form inclusion bodies requiring specialized extraction and refolding protocols.
The following storage and handling recommendations ensure optimal stability and activity of recombinant Aas protein:
| Parameter | Recommendation |
|---|---|
| Long-term storage | -20°C/-80°C |
| Working storage | 4°C for up to one week |
| Storage buffer | Tris/PBS-based buffer, 6% Trehalose, pH 8.0 |
| Reconstitution | Deionized sterile water to 0.1-1.0 mg/mL |
| Recommended additives | 5-50% glycerol (final concentration) |
| Special precautions | Avoid repeated freeze-thaw cycles |
| Aliquoting | Necessary for multiple use |
Before opening, vials should be briefly centrifuged to bring contents to the bottom . For long-term storage, adding glycerol to a final concentration of 5-50% is recommended, with 50% being the default recommendation .
To confirm that recombinant Aas protein maintains its native biological functions, researchers should implement these validation approaches:
Biochemical characterization:
Enzymatic activity assays targeting predicted bifunctional activities
Binding assays with potential interaction partners
Circular dichroism to confirm proper secondary structure
Functional complementation:
Generate aas gene knockout in Salmonella
Test whether recombinant protein can restore wild-type phenotypes
Compare effects of wild-type versus mutant versions of the protein
Structural validation:
Confirm protein folding through biophysical techniques
Verify absence of aggregation through size-exclusion chromatography
Assess thermal stability through differential scanning fluorimetry
While specific roles of Aas in pathogenesis are not directly addressed in the search results, researchers can apply approaches used for other Salmonella proteins:
Gene knockout studies: Create aas deletion mutants and evaluate:
Transcriptional analysis:
Determine expression patterns of aas during different growth phases
Measure aas expression during host cell infection
Identify regulatory elements controlling aas expression
Host interaction studies:
Assess whether Aas protein interacts with host cell components
Determine if Aas elicits immune responses during infection
Evaluate potential roles in immune evasion mechanisms
Comparative genomic approaches can uncover important evolutionary insights:
Sequence comparison analysis:
Align aas genes from multiple Salmonella serovars
Identify conserved domains indicating essential functions
Detect variable regions potentially involved in host adaptation
Calculate selection pressures (dN/dS ratios) to identify positively selected sites
Structural prediction comparisons:
Generate structural models of Aas from different Salmonella strains
Compare predicted functional domains and active sites
Identify strain-specific structural features
Evolutionary context analysis:
Examine flanking genes to identify potential operons
Determine if aas has undergone horizontal gene transfer
Assess whether aas is an intact gene or pseudogene in different lineages
Given that S. paratyphi C has undergone significant selection pressure during human adaptation, as evidenced by differential nucleotide substitutions and pseudogenes , analyzing how these evolutionary forces have shaped the aas gene could provide valuable insights into its function.
While specific immunogenic properties of Aas protein are not directly addressed in the search results, insights can be drawn from studies of other Salmonella proteins:
Potential as vaccine candidate:
If Aas is an outer membrane or secreted protein, it may have immunogenic potential similar to other surface proteins
Recombinant Aas could be evaluated as a subunit vaccine component
Immunization studies could determine protective efficacy against challenge
Comparative approaches:
Other Salmonella outer membrane proteins (LamB, PagC, TolC, NmpC, and FadL) have shown significant immunoprotection when used as vaccines
Surface proteins such as SpaO and H1a elicited protective immune responses with protection rates of 58.3-66.7% and 41.7-58.3% respectively
Combination approaches, similar to SpaO+H1a mixtures that achieved 83.3-91.7% protection, could be explored
Robust experimental design requires appropriate controls:
Negative controls:
Buffer-only conditions matching storage buffer composition
Irrelevant recombinant protein expressed and purified under identical conditions
Heat-inactivated Aas protein to control for non-specific effects
Empty vector controls in expression studies
Positive controls:
Well-characterized proteins with similar biochemical properties
Native (non-recombinant) Aas protein if available
Positive control assays demonstrating system functionality
Technical validation controls:
Researchers should anticipate and plan for these potential challenges:
Expression and purification issues:
Protein solubility problems requiring optimization of expression conditions
Potential toxicity to E. coli expression host
Contamination with bacterial endotoxins requiring additional purification steps
Stability concerns:
Functional considerations:
Potential interference of His-tag with protein function
Absence of post-translational modifications present in native protein
Effects of E. coli expression on protein folding compared to Salmonella expression
Structure-function analysis requires multifaceted approaches:
Computational analysis:
Homology modeling based on related proteins with known structures
Identification of functional domains through sequence analysis
Prediction of active sites and binding interfaces
Mutagenesis strategies:
Site-directed mutagenesis of predicted key residues
Creation of truncation mutants to identify essential domains
Domain swapping between Aas proteins from different Salmonella strains
Biophysical characterization:
Circular dichroism to assess secondary structure content
Differential scanning calorimetry to measure thermal stability
X-ray crystallography or cryo-EM for high-resolution structural determination
When analyzing experimental data on Aas protein function:
Sources of variability:
Batch-to-batch differences in protein preparation
Storage duration effects on protein activity
Influence of buffer components on functional assays
Technical variations in experimental equipment
Statistical approaches:
Use appropriate statistical tests for comparative analyses
Include sufficient biological and technical replicates
Consider power analysis to determine adequate sample sizes
Report effect sizes along with statistical significance
Validation strategies:
Confirm key findings using alternative methodological approaches
Verify results across different experimental conditions
Compare data with predictions from computational analyses
Resolving contradictory results requires systematic investigation:
Methodological reconciliation:
Compare experimental protocols, identifying key differences
Standardize methods across laboratories when possible
Evaluate effects of protein tags on functional outcomes
Consider strain-specific differences in Aas protein
Contextual considerations:
Assess effects of experimental conditions (temperature, pH, ionic strength)
Evaluate impacts of bacterial growth phase on Aas function
Consider effects of host environment factors on protein activity
Collaborative approaches:
Conduct inter-laboratory validation studies
Share reagents and protocols to ensure comparability
Develop consensus methods for Aas functional characterization
Comparative analysis across Salmonella strains requires:
Standardized expression and purification:
Comprehensive characterization:
Compare sequence homology and identify strain-specific variations
Assess functional differences through identical assay conditions
Evaluate structural variations through biophysical techniques
Evolutionary context integration: